Prescription Drug Overdose Prevention Program

Prescription Drug Overdose Prevention Program
On June 5, 2017, Arizona Governor, Doug Ducey issued an emergency public health declaration to address the opioid crisis in Arizona.  This was in response to a growing national, and statewide epidemic of opioid misuse and abuse.  The declaration allowed law enforcement officers to be trained in the administration of naloxone, the updates to the AZ Opioid Prescribing Guidelines were updated to be finalized, and the passage of the Opioid Epidemic Act.  Although the emergency declaration was lifted on May 28, 2018, the fight against the opioid epidemic continues.  

The Coconino County Public Health Services District Prescription Drug Overdose Prevention Program is funded via grant with the Arizona Department of Health Services, Office of Injury Prevention.  The program is part of a statewide initiative to reduce the number of fatal opioid overdoses in Coconino County, implementing five public health strategies from the Arizona Rx Misuse and Abuse Toolkit, using five public health strategies from the Arizona Rx Misuse and Abuse Toolkit. 

Program staff located in Flagstaff have established contact with agencies throughout Coconino County to build partnerships and create awareness of resources pertaining to opioid use. For more information please call or email the listed contact information.

Contact info:  Candice Koenker, Program Manager  ckoenker@coconino.az.gov  (928)679-7264

                        Jacque Gencarelle, Program Coordinator jgencarelle@coconino.az.gov  (928)679-7279

Naloxone Distribution Flyer

Deterra Bag Flyer11.1.2018

Prescription Drug Misuse Education, Prevention and Response Efforts brochure.

RX Drug Drop Box Location Flyer: Side 1   Side 2

CC opioid related hospital visits

CC number of opioid deaths

Resources:

To request Naloxone training and Naloxone Kits from Sonoran Prevention Works: http://spwaz.org/

Treatment Locator: http://substanceabuse.az.gov/

Free Opioid Prescribing CME Courses: https://www.vlh.com/azprescribing/

Documents:

RX Drug Drop Box Location Flyer: Side 1   Side 2

 Arizona Rx Misuse and Abuse Initiative Overview: Other-RxMisuseandAbuseInitiativeStrategicSummaryJune2015.pdf  OR  RX Initiative.pdf

AZ Controlled Substance Prescription Monitoring Program (AZ CSPMP) Registration FAQs: AZ PMP Registration FAQs.pdf

Informational Links:

Substance Abuse and Mental Health Services Administration (SAMHSA) Prescription Drug Misuse and Abuse: https://www.samhsa.gov/topics/prescription-drug-misuse-abuse

Center for Disease Control (CDC) Opioid Overdose Webpage: https://www.cdc.gov/drugoverdose/index.html

National Institute on Drug Abuse (NIDA): https://www.drugabuse.gov/

Arizona Department of Health Services Opioid Epidemic Home Page: https://www.azdhs.gov/prevention/womens-childrens-health/injury-prevention/opioid-prevention/index.php

Coconino County Opioid Poisoning and Abuse among Coconino County Residents Report (June 2017): http://www.coconino.az.gov/DocumentCenter/View/17695/Opioid-Report-6-9-17-

The Arizona Opioid Report:  https://www.azdhs.gov/documents/audiences/clinicians/clinical-guidelines-recommendations/prescribing-guidelines/arizona-opioid-report.pdf

The Arizona Opioid Epidemic Act: https://azgovernor.gov/sites/default/files/related-docs/arizona_opioid_epidemic_act_policy_primer.pdf

Governor’s Office of Youth, Faith and Family Opioid Abuse and Misuse: http://substanceabuse.az.gov/substance-abuse/rethink-rx

University of Arizona Center for Rural Health; http://crh.arizona.edu/programs/prescription-drug-misuse-abuse-initiative

Links for Prescribers:

Newly revised Arizona Opioid Prescribing Guidelines;https://www.azdhs.gov/documents/audiences/clinicians/clinical-guidelines-recommendations/prescribing-guidelines/az-opioid-prescribing-guidelines.pdf

CDC Guidelines for Prescribing Opioids for Chronic Pain; https://www.cdc.gov/drugoverdose/pdf/Guidelines_Factsheet-a.pdf

The Arizona Opioid Epidemic Act Prescriber Requirements: https://pharmacypmp.az.gov/sites/default/files/Opioid%20Epidemic%20Act%20FAQ_04182018.pdf